Singulair-suicide link investigated
From Times Wire Reports
The Food and Drug Administration said it was investigating a possible link between Merck’s drug Singulair and suicide. The agency said it was reviewing reports involving mood changes and suicidal behavior in patients who had taken the allergy and asthma drug.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
